ArriVent BioPharma
AVBP
#7246
Rank
A$0.82 B
Marketcap
A$15.89
Share price
-6.57%
Change (1 day)
-49.56%
Change (1 year)

ArriVent BioPharma (AVBP) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$42.11 Million

According to ArriVent BioPharma's latest financial reports the company's total liabilities are A$42.11 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ArriVent BioPharma - Total liabilities on balance sheet (from 2022 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$38.73 M39.37%
2024-12-31A$27.79 M-94.01%
2023-12-31A$0.46 B17.91%
2022-12-31A$0.39 B15601.55%
2021-12-31A$2.5 M